Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07045597Completed
Trial of midazolam in Adenotonsillar hypertrophy (ATH) (2 arms), sponsored by Sohag University. Primary endpoint: Sedative effect of preanesthetic Midazolam. Started Mar 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07045597.